Bio Rad Laboratories Inc/ US0905722072 /
| 2024-04-19 8:50:08 PM | Chg. -1.52 | Volume | Bid8:50:30 PM | Ask8:50:30 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 279.51USD | -0.54% | 168,598 Turnover: 20.74 mill. |
279.18Bid Size: 100 | 279.77Ask Size: 400 | 6.49 bill.USD | - | - |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 493.4960 | 508.6900 | 499.3390 | 491.3710 | 490.9520 | ||||||
| Intangible Assets | 174.1130 | 133.1230 | 145.5000 | 199.5000 | 253.9000 | ||||||
| Long-Term Investments | 1,027.7360 | 2,655.7090 | 4,638.2050 | 9,561.1400 | 14,387.0060 | ||||||
| Fixed Assets | 2,296.3510 | 3,587.6220 | 5,828.7450 | 10,832.7650 | 15,786.7120 | ||||||
| Inventories | 594.8040 | 583.8150 | 554.0070 | 622.2530 | 572.2390 | ||||||
| Accounts Receivable | 464.8470 | 392.4430 | 392.6720 | 419.4240 | 423.5370 | ||||||
| Cash and Cash Equivalents | 383.8240 | 431.5260 | 660.6720 | 662.2050 | 470.7830 | ||||||
| Current Assets | 1,976.6490 | 2,023.4780 | 2,180.1550 | 2,139.8350 | 1,989.0880 | ||||||
| Total Assets | 4,273 | 5,611.1000 | 8,008.9000 | 12,972.6000 | 17,775.8000 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 135.1820 | 122.4500 | 107.0140 | 139.4510 | 141.9410 | ||||||
| Long-term debt | 434.6000 | 438.9000 | 13.6000 | 12.3000 | 10.5000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 222.2000 | 553.2000 | 997.8000 | - | - | ||||||
| Liabilities | 1,342.7500 | 1,590.7690 | 2,253.8430 | 3,092.6600 | 4,108.6660 | ||||||
| Share Capital | .0020 | .0020 | .0020 | .0020 | .0020 | ||||||
| Total Equity | 2,930.2500 | 4,020.3310 | 5,755.0570 | 9,879.9400 | 13,667.1340 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 4,273 | 5,611.1000 | 8,008.9000 | 12,972.6000 | 17,775.8000 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,160.2000 | 2,289.4150 | 2,311.6590 | 2,545.6260 | 2,922.5450 | ||||||
| Depreciation (total) | - | 138.1000 | 134.2000 | - | - | ||||||
| Operating Result | 116.6500 | -103.3410 | 229.6610 | 410.9570 | 489.4300 | ||||||
| Interest Income | 21.9140 | -23.9620 | -23.4160 | -21.8610 | -1.5510 | ||||||
| Income Before Taxes | 97.8000 | 512.7000 | 2,261.1000 | 4,907.6000 | 5,438.1000 | ||||||
| Income Taxes | 24.4000 | -147 | -502.4000 | -1,101.4000 | -1,192.2000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 122.2000 | 365.6000 | 1,758.7000 | 3,806.2670 | 4,245.9020 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 103.9000 | 285.5000 | 457.9000 | 575.3000 | 656.5000 | ||||||
| Cash Flow from Investing Activities | -175.5720 | -186.9780 | -208.8890 | -60.2500 | -784.4380 | ||||||
| Cash Flow from Financing | .3410 | -48.6800 | -22.7580 | -523.0410 | -55.4290 | ||||||
| Decrease / Increase in Cash | -72.4400 | 49.1810 | 228.4870 | 4.4640 | -195.9820 | ||||||
| Employees | 8,150 | 8,260 | 8,120 | - | - | ||||||
